Melatonin nanoparticles inhibit mutant hematopoiesis & restore bone marrow architecture in myeloproliferative neoplasms
Siddharth Gupta, Alessandro Motta, Sara Elsafy, Shiva Khorshid et autres
0 citationsbioRxiv (Cold Spring Harbor Laboratory)
Kathrin Olschok
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
23Publications signalées
134Citations signalées
5Affiliations récentes
Institutions déclarées
Domaines associés
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia ResearchEndoplasmic Reticulum Stress and DiseaseChronic Myeloid Leukemia TreatmentsImmune Cell Function and Interaction
Publications récentes
Liposomal melatonin targets mutant hematopoiesis and bone marrow remodeling in MPN
Siddharth Gupta, Alessandro Motta, Sara Elsafy, Julian Baumeister et autres
0 citationsBlood
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alfa
Milena Kalmer, Martin Graßhoff, Tiago Maié, Kristina Pannen et autres
2 citationsBlood Advances
Proinflammatory phenotype of iPS cell-derived JAK2 V617F megakaryocytes induces fibrosis in 3D in vitro bone marrow niche
Niclas Flosdorf, Janik Böhnke, Marcelo A. S. Toledo, Niklas Lutterbach et autres
16 citationsStem Cell Reports
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms
Jessica E. Pritchard, Juliette E. Pearce, Inge Snoeren, Stijn Fuchs et autres
9 citationsCell Reports
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alpha
Milena Kalmer, Martin Graßhoff, Tiago Maié, Kristina Pannen et autres
2 citationsResearch Square
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
Kathrin Olschok, Bianca Altenburg, Marcelo A. S. Toledo, Angela Maurer et autres
14 citationsFrontiers in Oncology
P1008: THE TELOMERASE INHIBITOR IMETELSTAT DIFFERENTIALLY TARGETS JAK2V617F- VERSUS CALR-MUTANT MYELOPROLIFERATIVE NEOPLASM CELLS AND INHIBITS JAK-STAT SIGNALING
Kathrin Olschok, Bianca Altenburg, Marcelo A. S. Toledo, Angela Maurer et autres
1 citationHemaSphere
Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Juan G. Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo et autres
0 citations
Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Juan G. Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo et autres
0 citations
Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Juan G. Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo et autres
0 citations
Supplementary Data from Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms
Juan G. Ibarra, Yassmin A. Elbanna, Katarzyna Kuryłowicz, Michele Ciboddo et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.